Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion type Assertion NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_head.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion description "[The JAK2(V617F) mutation, which has been found in patients with myeloproliferative disorders (MPD), has not yet been evaluated in lymphoproliferative disorders by any adequately sensitive techniques.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_provenance.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion evidence source_evidence_literature NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_provenance.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion SIO_000772 18032883 NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_provenance.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion wasDerivedFrom befree-2016 NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_provenance.
- NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_assertion wasGeneratedBy ECO_0000203 NP641745.RADi7KxEPXKm0AjIUtg-9xvyomFy0ltdI3sA9csasLFl4130_provenance.